Physician profile
John Robert Fox
NPI 1689779191
$2,426.80
in general payments reported to CMS, 2019-2025
8 companies · $45.43 in 2025
The $45.43 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.69 · 2020: $17.96 · 2021: $19.14 · 2022: $18.96 · 2023: $2,165 · 2024: $114 · 2025: $45.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,086 · Food and Beverage: $203 · Travel and Lodging: $35.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,086.00 |
| Food and Beverage | $202.80 |
| Travel and Lodging | $35.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,100.34 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $117.74 | 2023-2025 | Libtayo, Dupixent |
| Glaxosmithkline, LLC. | $56.06 | 2020-2022 | |
| Janssen Biotech, INC. | $46.69 | 2019 | |
| Almirall LLC | $37.10 | 2023-2024 | Klisyri, Seysara |
| Corium, LLC | $24.07 | 2025 | Azstarys |
| Pfizer INC. | $23.23 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.57 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.